Recall of One Lot Hospira Hydromorphone Hydrochloride Injection
Published: Aug 16, 2012
Hospira and the U.S. Food and Drug Administration (FDA) are notifying healthcare professionals of a nationwide voluntary recall of one lot of Hydromorphone Injection, USP, 2 mg/mL, (C-II), 1 mL fill in 2.5 mL Carpuject, NDC 0409-1312-30, due to a reported complaint of a single Carpuject containing more than the 1 mL labeled fill volume. Overdose of ppioid pain medications such as Hydromorphone can cause respiratory depression,, low blood pressure and reduced heart rate including circulatory collapse.
The affected product is a prefilled glass cartridge for use with the Carpuject Syringe system. The affected lot number is 12720LL. The expiration date is December 1, 2013 and was distributed in March - May 2012. Hospira has not received any reports of adverse events related to this issue for this lot.
Want to read the full alert and receive alert emails?
